Stress sensitization induced by stressor and methamphetamine

Japanese Journal of Neuropsychopharmacology

Volumn 24, Issue 3, 2004, Pages 151-157

  Yui, Kunio ^a,c   Ikemoto, Shigenori ^a,b  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b NIPPON VETERINARY AND LIFE SCIENCE UNIVERSITY   (Japan)

^c Medical Care Section   (Japan)

Author keywords

Immediate early gene expression; Methamphetamine; Paranoid hallucinatory psychosis; Schizophrenia; Stress sensitization

Indexed keywords

4 HYDROXY 3 METHOXYPHENYLETHYLENE GLYCOL; AMPHETAMINE; CLOZAPINE; HALOPERIDOL; METHAMPHETAMINE; NORADRENALIN;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; CAUDATE NUCLEUS; CHRONOPHARMACOLOGY; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; DOPAMINERGIC TRANSMISSION; EMOTIONAL STRESS; ENVIRONMENTAL FACTOR; GENE EXPRESSION; HEREDITY; IMMEDIATE EARLY GENE; MENTAL STRESS; NEUROBIOLOGY; NEUROPHARMACOLOGY; NONHUMAN; NUCLEUS ACCUMBENS; PATHOPHYSIOLOGY; PREFRONTAL CORTEX; PUTAMEN; REVIEW; SCHIZOPHRENIA; SENSITIZATION; SHOCK;

AMPHETAMINE; ANIMALS; BEHAVIOR, ANIMAL; BRAIN; CENTRAL NERVOUS SYSTEM STIMULANTS; DISEASE MODELS, ANIMAL; GUINEA PIGS; HALLUCINATIONS; HUMANS; METHAMPHETAMINE; MICE; RATS; SCHIZOPHRENIA; STRESS; SUBSTANCE-RELATED DISORDERS; SYNAPTIC TRANSMISSION;

EID: 3242808349     PISSN: 13402544     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (62)

1. Antelman, S. M., Eichler, A. J., Black, C. A. and Kocan, D. (1980) Interchangeability of stress and amphetamine in sensitization. Science, 207: 329-331.
2. Badiani, A. Cabib, S. and Puglisi-Allegra, S. (1992) Chronic stress induces strain-dependent sensitization to the behavioral effects of amphetamine in the mouse. Pharmacol Biochem Behav, 43: 53-60.
3. Basta-Kaim, A., Budziszewska, B., Jaworska-Feil, L., LeAkiewicz, M., Tetich, M., Kubera, M., Scharpe, S. and Lason, W. (2003) Opposite effects of clozapine and sulpiride on the lipopolysacchride-induced inhibition of the GR-mediated gene transcription in fibroblast cells. Pol J Pharmacol, 55: 1153-1158.
4. Cabib, S., Zocchi, A. and Puglisi-Allegra, S. (1995) A comparison of the behavioral effects of minaprine, amphetamine and stress. Psychopharmacology, 121: 73-80.
5. Camp, D. M. and Robinson, T. E. (1988) Susceptibility to sensitization. II. The influence of gonadal hormones on enduring changes in brain monoamines and behavior produced by the repeated administration of D-amphetamine or restraint stress. Behav Brain Res, 30: 69-88.
6. Cassens, G., Roffman, M., Kuruc, A., Orsulak, P. J. and Schildkraut, J. J. (1980) Alterations in brain norepinephrine metabolism induced by environmental stimuli previously paired with inescapable shock. Science, 209: 1138-1140.
7. Ciompi, L. (1994) Affect logic: An integrative model of the psyche and its relations to schizophrenia. Br J Psychiatry, 164: 51-55.
8. Connell, P. H. (1958) Amphetamine psychosis. Maudsley Monographs, No. 5, Oxford University Press, London.
9. 2 dopamine and opiate receptors are involved in the restrain stress-induced sensitization to the psychostimulant effects of amphetamine. Pharmacol Biochem Behav, 58: 9-14.
10. Fowles, D. C. (1992) Schizophrenia: Diathesis-stress revisited. Ann Rev Psychol, 43: 303-336.
11. Glavin, G. B. (1985) Stress and brain noradrenaline: A review. Neurosci Biobehav Rev, 9: 233-243.
12. Howes, O. D., McDonaldd, C., Cannon, M., Arseneault, L., Boydell, J. and Murray, R. M. (2004) Pathways to schizophrenia: The impact of environmetal factors. Int J Neuropsychopharmacol, 7 (Suppl): S7-S13.
13. Irwin, J., Ahluwalia, P. and Anisman, H. (1986) Sensitization of norepinephrine activity following acute and chronic footshock. Brain Res, 379: 98-103.
14. Kajii, Y., Muraoka, S., Hiraoka, S., Fujiyama, K., Umino, A. and Nishikawa, T. (2003) A developmentally regulated and psychostimulant-inducible novel rat gene mrtl encoding PDZ-PX protein isolated in the neocortex. Mol Psychiatry, 8: 434-444.
15. Kalivas, P. W. (1995) Interactions between dopamine and excitatory amino acids in behavioral sensitization to psychostimulants. Drug Alcohol Depend, 37: 95-100.
16. Karler, R., Finnegan, K. T. and Calder, L. D. (1993) Blockade of behavioral sensitization to cocaine and amphetamine by inhibitors of protein synthesis. Brain Res, 603: 19-24.
17. Kato, N. and Hada, H. (1959) Biochemical studies on addiction due to β-phenylisopropylmethylamine: Effects of several substances related to methamphetamine and hallucinogens on glucose metabolism in brain tissue. Psychiatr Neurol Jpn, 61: 1252-1258.
18. Koenig, J. I., Kirkpatrick, B. and Lee, P. (2002) Glucocorticoid hormones and early brain development in schizophrenia. Neuropsychopharmacology, 27: 309-318.
19. Kontkanen, O., Lakso, M., Wong, G. and Castren, E. (2002) Chronic antipsychotic drug treatment induces long-lasting expression of fos and jun family genes and activator protein 1 complex in the rat prefrontal cortex. Neuropsychopharmacology, 27: 152-162.
20. Laruelle, M. (2000) The role of endogenous sensitization in the pathophysiology of schizophrenia: Implications from recent brain imaging studies. Brain Res Rev, 31: 371-384.
21. Lieberman, J. A., Sheitman, B. B. and Kinon, B. J. (1997) Neurochemical sensitization in the pathophysiology of schizophrenia: Deficits and dysfunction in neuronal regulation and plasticity. Neuropsychopharmacology, 17: 205-229.
22. Machiyama, Y. (1992) Chronic methamphetamine intoxication model of schizophrenia in animals. Schizophr Bull, 18: 107-113.
23. Marcus, M. M., Malmerfelt, A., Nyberg, S. and Svensson, T. H. (2002) Biochemical effects in brain of low doses of haloperidol are qualitatively similar to those of high doses. Eur Neuropsychopharmacol, 12: 379-386.
24. Nisenbaum, L. K., Zigmond, M. J. Sved, A. F. and Abercrombie, E. D. (1991) Prior exposure to chronic stress results in enhanced synthesis and release of hippocampal norepinephrine in response to a novel stressor. J Neurosci, 11: 1478-1484.
25. Nuechterlein, K. H., Dawson, M. E., Ventura, J., Gitlin, M., Subotnik, K. L., Snyder, K. S., Mintz, J. and Bartzokis, G. (1994) The vulnerability/stress model of schizophrenic relapse: A longitudinal study. Acta Psychiatr Scand, 89: 58-64.
26. Ostrander, M. M., Richtand, N. M. and Herman, J. P. (2003) Strsss and amphetamine induces Fos expression in medial prefrontal cortex neurons containing glucocorticoid receptors. Brain Res, 990: 209-214.
27. Pacchioni, A. M., Gioino, G., Assis, A. and Cancela, L. M. (2002) A single exposure to restraint stress induces behavioral and neurochemical sensitization to stimulating effects of amphetamine. Ann NY Acad Sci, 965: 233-246.
28. Persico, A. M., Schindler, C. W., O'Hara, B. F., Brannock, M. T. and Uhl, G. R. (1993) Brain transcription factor expression: Effects of acute and chronic amphetamine and injection stress. Molecular Brain Res, 20: 91-100.
29. Petty, F., Chae, Y., Kramer, G., Jordan, S. and Wilson, L. (1994) Learned helplessness sensitizes hippocampal norepinrephrine to mild restress. Biol Psychiatry, 35: 903-908.
30. Reid, M. S., Ho, L. B., Tolliver, B. K., Wolkowitz, O. M. and Berger, S. P. (1998) Partial reversal of stress-induced behavioal sensitization to amphetamine following metyrapone treatment. Brain Res, 783: 133-142.
31. Robinson, T. E. and Becker, J. B. (1986) Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosis. Brain Res, 396: 157-198.
32. Rodriguez, J. J., Garcia, D. R., Nakabeppu, Y. and Pickel, V. M. (2001) FosB in rat striatum: Normal regional distribution and enhanced expression after 6-month haloperidol administration. Synapse, 39: 122-132.
33. Sato, M., Chen, C.-C., Akiyama, K. and Otsuki, S. (1983) Acute exacerbation of paranoid psychotic state after lomg-term abstinence in patientas with previous methamphetamine psychosis. Biol Psychiatry, 18: 429-440.
34. Sato, M. (1992) A lasting vulnerability to psychosis in patients with previous methamphetamine psychosis. Ann NY Acad Sci, 654: 160-170.
35. Sato, M., Numachi, Y. and Hamamura, T. (1992) Relapse of paranoid psychotic state in methamphetamine model of schizophrenia. Schizophr Bull, 18: 115-122.
36. Seillier, A., Coutureau, E., Thiriet, N., Herbeaux, K., Zwiller, J., Di Scala, G., Will, B. and Majchrzak, M. (2003) Bilateral lesions of the entorhinal cortex differentially modify haloperidol- and olanzapine-induced c-fos mRNA expression in the rat forebrain. Neuropharmacology, 45: 190-200.
37. Shilling, P. D., Kelsoe, J. R. and Segal, D. S. (1997) Dopamine transporter mRNA is up-regulated in the substantia nigra and the ventral tegmental area of amphetamine-sensitized rats. Neurosci Lett, 236: 131-134.
38. Shimazono, Y. and Matsushima, E. (1995) Behavioral and neuroimaging studies on schizophrenia in Japan. Psychiatr Clin Neurosci, 49: 3-11.
39. Stanton, M. D., and Bardoni, A. (1972) Drug flashbacks: Reported frequency in a military population. Am J Psychiatry, 129: 751-755.
40. Ujike, H., Takaki, M., Kodama, M. and Kuroda, S. (2002) Gene expression related to synaptogenesis, neuritogenesis, and MAP kinase in behavioral sensitization to psychostimulants. Ann NY Acad Sci, 965: 55-67.
41. Uslaner, J., Badiani, A., Day, H. E. W., Watson, S. J., Akil, H. and Robinson, T. E. (2001) Enviornmental context modulates the ability of cocaine and amphetamine to induce c-fos mRNA expression in the neocortex, caudate nucleus, and nucleus accumbens. Brain Res, 920: 106-116.
42. Utena, H., Ezoe, T., Kato, N. and Hada, H (1959) Effects of chronic administration of methamphetamine on enzymic patterns in brain tissue. J Neurochem, 4: 161-169.
43. Utena, H., Takano, S., Yuasa, S., Shimizu, T. and Kato, T. (1961) Behavioral abnormalities in animals and metabolic changes in the brain. Brain Nerve, 13: 687-695.
44. Utena, H. and Hirao, T. (1964) Formulation of normal and aberrant behavior chains. Brain Nerve, 16: 31-39.
45. Utena, H. (1966) Behavioral aberrations in methamphetamine-intoxicated animals and chemical correlates in the brain. Prog Brain Res, 21B: 192-207.
46. Utena, H. and Machiyama, U. (1971) Schizophrenia model in animals. Vestn Akad Med Nauk SSSR, 26: 64-67.
47. Vaille, C. (1992) Multiple drug addiction. Ann Pharm Fr, 50: 59-67.
48. van Kammen, D. P., Docherty, J. P. and Bunney, W. E. (1982) Predection of early relapse after pimozide discontinuation by response to d-amphetamine during pimozide treatment. Biol Psychiatry, 17: 233-242.
49. Yui, K., Goto, K., Ikemoto, S. and Ishiguro, T. (1997) Methamphetamine psychosis: Spontaneous recurrence of paranoid-hallucinatory states and monoamine neurotransmitter function. J Clin Psychopharmacol, 17: 34-43.
50. Yui, K., Goto, K., Ikemoto, S., Ishiguro, T., Angrist, B., Ducan, G. E., Sheitman, B. B., Lieberman, J. A., Bracha, S. H. and Ali, S. F. (1999) Neurobiological basis of relapse prediction in stimulant-induced psychosis and schizophrenia: The role of sensitization. Mol Psychiatry, 4: 512-523.
51. Yui, K., Goto, K., Ikemoto, S. Ishiguro, T. and Kamata, Y. (2000) Increased sensitivity to stress in spontaneous recurrence of methamphetamine psychosis: Noradrenergic hyperactivity with contribution from dopaminergic hyperactivity. J Clin Psychopharmacol, 20: 165-174.
52. Yui, K., Ikemoto, S., Goto, K., Nishijima, K. and Kato, S. (2003) Susceptibility to episode recurrence in spontaneous recurrence of methamphetamine psychosis. J Clin Psychopharnmacol, 23: 525-528.
53. Yin, H.-S., Chen, C.-T. and Lin, T.-Y. (2004) Age- and region dependent alterations in the GABAergic innervation in the brain of rats treated with amphetamine. Int J Neuropsychopharmacol, 7: 35-48.
54. Wang, Y.-M., Gainetdinov, R. R., Fumagalli, F., Xu, F., Jones, S. R., Bock, C. B., Miller, G. W., Wightman, R. M. and Caron, M. G. (1997) Knockout of the vesicular monoamine transporter 2 gene results in neonatal death and supersensitivity to cocaine and amphetamine. Neuron, 19: 1285-1296.
55. Zubin, J., Steinhauer, S. R. and Condray, R. (1992) Vulnerability to relapse in schizophrenia. Br J Psychiatry, 161: 13-18.